TES Pharma is a research-based biopharmaceutical company.
TES Pharma has raised $5.2M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
TES Pharma's investors include Indaco Venture Partners, XGEN Venture, Foro delle Arti.
TES Pharma is headquartered in Perugia, Italy.
TES Pharma is a research-based biopharmaceutical company.
TES Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TES Pharma — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/tes-pharma. Accessed September 30, 2026.
VCBacked. (2024). TES Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/tes-pharma
{{cite web |title=TES Pharma — Funding & Investors |url=https://www.vcbacked.co/company/tes-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated